Irish Biotech Secures Strong Funding: Deciphex and Aerska Lead the Way

Funding rounds for Deciphex (€15m) and Aerska (€18m) have rounded off a strong week for Irish biotech companies. These recent investments highlight the growing strength and potential of the Irish biotechnology sector.

Deciphex, a company specializing in digital pathology solutions, secured €15 million in funding. Aerska, focused on developing novel therapies for respiratory diseases, raised €18 million. These investments demonstrate confidence in the innovative work being done by Irish biotech firms and their potential to deliver significant advancements in healthcare.